No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs16866420 |
chr2:179491235-179491236 |
Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs148273037 |
chr2:179491254-179491255 |
Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs73038310 |
chr2:179491257-179491258 |
Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
4 |
rs114233724 |
chr2:179491270-179491271 |
Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs73973132 |
chr2:179491278-179491279 |
Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs570869479 |
chr2:179491307-179491308 |
Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs56352103 |
chr2:179491330-179491331 |
Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs55639922 |
chr2:179491331-179491332 |
Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
9 |
rs575225181 |
chr2:179491337-179491338 |
Weak transcription Strong transcription Enhancers Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs147298895 |
chr2:179491405-179491406 |
Weak transcription Strong transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs374140197 |
chr2:179491408-179491409 |
Weak transcription Strong transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs554952102 |
chr2:179491428-179491429 |
Weak transcription Strong transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs575004412 |
chr2:179491452-179491453 |
Weak transcription Strong transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs540939476 |
chr2:179491467-179491468 |
Weak transcription Strong transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs544348023 |
chr2:179491492-179491493 |
Weak transcription Strong transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs533432035 |
chr2:179491562-179491563 |
Weak transcription Strong transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs368052682 |
chr2:179491567-179491568 |
Weak transcription Strong transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs192709237 |
chr2:179491570-179491571 |
Weak transcription Strong transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs577543038 |
chr2:179491609-179491610 |
Weak transcription Strong transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs184119501 |
chr2:179491707-179491708 |
Weak transcription Strong transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs140875948 |
chr2:179491712-179491713 |
Weak transcription Strong transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|